- Report
- March 2025
- 180 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- October 2024
- 182 Pages
Global
From €3228EUR$3,545USD£2,776GBP
€3587EUR$3,939USD£3,085GBP
- Report
- April 2025
- 194 Pages
Global
From €5327EUR$5,850USD£4,582GBP
- Report
- February 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,516GBP
- Report
- August 2024
- 141 Pages
Global
From €2731EUR$2,999USD£2,349GBP
- Report
- December 2024
- 152 Pages
Global
From €3597EUR$3,950USD£3,093GBP
- Report
- July 2024
- 150 Pages
Global
From €3415EUR$3,750USD£2,937GBP
- Clinical Trials
- June 2024
- 240 Pages
Global
From €2732EUR$3,000USD£2,349GBP
- Report
- July 2024
- 196 Pages
Global
From €4326EUR$4,750USD£3,720GBP
- Report
- May 2024
- 182 Pages
Global
From €4098EUR$4,500USD£3,524GBP
- Report
- March 2025
- 175 Pages
Global
From €4089EUR$4,490USD£3,516GBP
- Report
- June 2024
- 200 Pages
Global
From €7240EUR$7,950USD£6,226GBP
- Drug Pipelines
- July 2024
- 180 Pages
Global
From €2277EUR$2,500USD£1,958GBP
- Report
- December 2024
- 70 Pages
Global
From €3638EUR$3,995USD£3,129GBP
- Report
- April 2025
- 200 Pages
Global
From €4089EUR$4,490USD£3,516GBP
- Report
- December 2024
- 30 Pages
Global
From €2504EUR$2,750USD£2,154GBP
- Report
- December 2024
- 30 Pages
Global
From €2504EUR$2,750USD£2,154GBP
- Report
- December 2024
- 30 Pages
Global
From €2504EUR$2,750USD£2,154GBP
- Report
- October 2024
- 140 Pages
Global
From €2277EUR$2,500USD£1,958GBP
- Report
- February 2025
- 135 Pages
Global
From €13656EUR$14,995USD£11,744GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more